UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048510
Receipt number R000055234
Scientific Title Randomized controlled trials to verify that inhalation of beta-caryophyllene improves vascular wall hardening and lowers baPWV
Date of disclosure of the study information 2022/08/15
Last modified on 2022/07/27 11:11:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized controlled trials to verify that inhalation of beta-caryophyllene improves vascular wall hardening and lowers baPWV

Acronym

Randomized controlled trials to verify that inhalation of beta-caryophyllene improves vascular wall hardening and lowers baPWV

Scientific Title

Randomized controlled trials to verify that inhalation of beta-caryophyllene improves vascular wall hardening and lowers baPWV

Scientific Title:Acronym

Randomized controlled trials to verify that inhalation of beta-caryophyllene improves vascular wall hardening and lowers baPWV

Region

Japan


Condition

Condition

smokers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To test whether inhalation and ingestion of beta-caryophyllene concurrently with smoking suppresses the increase in brachial-ankle pulse wave velocity (baPWV).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Decrease in Brachial-ankle Pulse Wave Velocity 12 weeks after the start of study

Key secondary outcomes

Improving the experience


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Cigarettes filled with capsules of the following contents were supplied to the filter part of cigarettes that normally smoke. The capsules were destroyed immediately before smoking and then smoked at discretion.
beta-caryophyllene 5.79 mg, MCT 13.51 mg

Interventions/Control_2

Cigarettes filled with capsules of the following contents were supplied to the filter part of cigarettes that normally smoke. The capsules were destroyed immediately before smoking and then smoked at discretion.
beta-caryophyllene 2.90 mg, MCT 16.40 mg

Interventions/Control_3

Cigarettes filled with capsules of the following contents were supplied to the filter part of cigarettes that normally smoke. The capsules were destroyed immediately before smoking and then smoked at discretion.
MCT 19.30 mg (Placebo)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Healthy adult men and women smokers who smoke regular cigarettes

Key exclusion criteria

Non-smokers, smokers who smoke cigarettes other than cigarettes (pipes, etc.), smokers who smoke non-regular type (slim type) cigarettes, those who plan to quit during the period, are being treated for illness or those who need or plan to treat their illness, those who wish to become pregnant during the period, those who are pregnant / lactating, those who take medicine, those who take health foods (excluding products of active ingredients are only vitamins and minerals) on a daily basis

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yoshiharu
Middle name
Last name Matahira

Organization

Sunsho Pharmaceutical Co.,Ltd.

Division name

Innovation Center

Zip code

418-0013

Address

533-2, Oiwa, Fujinomiya Shi, Shizuoka Ken, 418-0013, Japan

TEL

0544-25-7799

Email

y.matahira@sunsho.co.jp


Public contact

Name of contact person

1st name Kazuya
Middle name
Last name Yamada

Organization

Sunsho Pharmaceutical Co.,Ltd.

Division name

Innovation Center

Zip code

419-0201

Address

1468, Atsuhara, Fuji Shi, Shizuoka Ken, 419-0201, Japan

TEL

0545-73-0610

Homepage URL


Email

kazuya.yamada@sunsho.co.jp


Sponsor or person

Institute

Sunsho Pharmaceutical Co.,Ltd.

Institute

Department

Personal name



Funding Source

Organization

Sunsho Pharmaceutical Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sansho Pharmaceutical Co., Ltd. Ethics Review Board

Address

1468, Atsuhara, Fuji Shi, Shizuoka Ken, 419-0201, Japan

Tel

0545-73-0610

Email

masaki.ookawara@sunsho.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

19

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 08 Month 24 Day

Date of IRB

2021 Year 08 Month 26 Day

Anticipated trial start date

2021 Year 09 Month 01 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 07 Month 29 Day

Last modified on

2022 Year 07 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055234